Neurocrine Biosciences (NASDAQ:NBIX – Get Free Report) was upgraded by equities researchers at StockNews.com from a “buy” rating to a “strong-buy” rating in a research report issued on Monday. A ...

Tokio Marine Asset Management Co. Ltd. cut its holdings in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 2.8% ...

Kevin Charles Gorman, a director at Neurocrine Biosciences Inc. (NASDAQ:NBIX), recently sold a significant portion of his holdings in the company. According to a recent SEC filing, Gorman sold 146,105 ...

Maria is best known for her work on steroid 21-hydroxylase deficiency, the most common form of congenital adrenal hyperplasia (CAH). Most of her fellows and trainees in the late 1970s and early 1980s ...

Adrenal tumors are a heterogeneous group of tumors characterized by diverse biology and clinical courses. They may be associated with high malignant potential and/or hormonal activity, leading to ...